Clinical Trial Design (eBook)
368 Seiten
John Wiley & Sons (Verlag)
978-1-118-18330-4 (ISBN)
issues involved in clinical trials using statistical
methods
There has been enormous interest and development in Bayesian
adaptive designs, especially for early phases of clinical trials.
However, for phase III trials, frequentist methods still play a
dominant role through controlling type I and type II errors in the
hypothesis testing framework. From practical perspectives, Clinical
Trial Design: Bayesian and Frequentist Adaptive Methods provides
comprehensive coverage of both Bayesian and frequentist approaches
to all phases of clinical trial design. Before underpinning various
adaptive methods, the book establishes an overview of the
fundamentals of clinical trials as well as a comparison of Bayesian
and frequentist statistics.
Recognizing that clinical trial design is one of the most
important and useful skills in the pharmaceutical industry, this
book provides detailed discussions on a variety of statistical
designs, their properties, and operating characteristics for phase
I, II, and III clinical trials as well as an introduction to phase
IV trials. Many practical issues and challenges arising in clinical
trials are addressed. Additional topics of coverage include:
* Risk and benefit analysis for toxicity and efficacy
trade-offs
* Bayesian predictive probability trial monitoring
* Bayesian adaptive randomization
* Late onset toxicity and response
* Dose finding in drug combination trials
* Targeted therapy designs
The author utilizes cutting-edge clinical trial designs and
statistical methods that have been employed at the world's leading
medical centers as well as in the pharmaceutical industry. The
software used throughout the book is freely available on the book's
related website, equipping readers with the necessary tools for
designing clinical trials.
Clinical Trial Design is an excellent book for courses on the
topic at the graduate level. The book also serves as a valuable
reference for statisticians and biostatisticians in the
pharmaceutical industry as well as for researchers and
practitioners who design, conduct, and monitor clinical trials in
their everyday work.
GUOSHENG YIN, PhD, is Associate Professor in the Department of Statistics and Actuarial Science at The University of Hong Kong, and Adjunct Associate Professor in the Department of Biostatistics at The University of Texas MD Anderson Cancer Center.
Preface xv
1. Introduction 1
2. Fundamentals of Clinical Trials 13
3. Frequentist versus Bayesian Statistics 29
4. Phase I Trial Design 77
5. Phase II Trial Design 115
6. Phase III Trial Design 159
7. Adaptive Randomization 223
8. Late-Onset Toxicity 253
9. Drug-Combination Trials 271
10. Targeted Therapy Design 297
References 311
Author Index 329
Subject Index 333
"In summary, this book is useful for anyone interested in
design and analysis of clinical studies. The main strengths of this
book are the well-balanced approach between statistical theories
and statistical analysis methods of the design issues involved in
clinical trials. I would suggest the usage of this book as a
Master's level course in biostatistics."
(Journal of Biopharmaceutical Statistics, 1 May 2013)
"The author should be commended; the text is well written
and packed with information that belies the book's trim
size." (Drug Information Journal, 30 October 2012)
"The book accompanied with software developed at MD
Anderson Cancer Center provides an excellent reference for everyone
who works in clinical trial field." (Biometrics,
1 July 2012)
Erscheint lt. Verlag | 6.1.2012 |
---|---|
Sprache | englisch |
Themenwelt | Mathematik / Informatik ► Mathematik ► Statistik |
Mathematik / Informatik ► Mathematik ► Wahrscheinlichkeit / Kombinatorik | |
Medizin / Pharmazie ► Medizinische Fachgebiete | |
Schlagworte | Clinical Trials • Klinische Studien • Medical Science • Medizin • Medizinische Statistik • Pharmaceutical Statistics • Pharmazeutische Statistik • Statistics • Statistik |
ISBN-10 | 1-118-18330-4 / 1118183304 |
ISBN-13 | 978-1-118-18330-4 / 9781118183304 |
Haben Sie eine Frage zum Produkt? |
Größe: 16,2 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich